Selection of blockbuster announcements

1. Byd Company Limited: sales of new energy vehicles in October were 217800, up 168.78% from the same period last year.

$BYD COMPANY (01211.HK)$It was revealed that KuaiBao produced and sold in October 2022, and the monthly sales of new energy vehicles were 217816, an increase of 168.78 percent over the same period last year. From January to October, sales of new energy vehicles totaled 1397870, an increase of 233.92 percent over the same period last year. At the same time, the company sold a total of 9529 new energy passenger cars overseas in October 2022. The total installed capacity of the power battery and energy storage battery of the new energy vehicle in October 2022 is about 10.188GWh, and the total installed capacity in 2022 is about 67.681GWh.

2. Guangzhou Automobile Group: car sales in October were 212400, up 10.16% from the same period last year.

$GAC GROUP (02238.HK)$It was announced that KuaiBao produced and sold in October 2022. The company's car production in October 2022 was 234815, an increase of 21.93 percent over the same period last year. This year's cumulative production was 2067449, an increase of 26.35 percent over the same period last year. October car sales were 212455, up 10.16 percent from the same period last year, and the cumulative sales this year was 2037495, an increase of 20.81 percent over the same period last year. Among them, sales of new energy vehicles in October were 33598, up 135.15% from the same period last year. GAC Aian sold 30063 vehicles in October, up 149.20% from January to October, with cumulative sales of 212384 vehicles, an increase of 134.37% over the same period last year.

3. Zijin Mining Group: plans to acquire 30% stake in Luoyang Yinhui with 7 billion yuan.

$ZIJIN MINING (02899.HK)$According to the announcement, the company signed an equity transfer contract with Luoyang Industries on November 3, 2022, and Luoyang Industrial transferred its 30% stake in Luoyang Yinhui to the company at a consideration of 7 billion yuan. Upon completion of the transaction, the company will hold a 100% stake in Luoyang Yinhui.

4. Cosco Haineng: it is proposed to increase the capital of CLNG by US $43.5 million

$COSCO SHIP ENGY (01138.HK)$(01138) announcement that COSCO Marine Energy Transportation Co., Ltd. will increase its capital to China liquefied Natural Gas Transportation (Holdings) Co., Ltd. (hereinafter referred to as "CLNG") according to the progress of the project, and the amount of capital increase is expected to be 43.5 million US dollars.

5. China Unicom: the Ministry of Industry and Information Technology has approved the re-cultivation of 900MHz band spectrum resources.

$CHINA UNICOM (00762.HK)$It was announced that the company's final parent company, China United Network Communications Group Co., Ltd., has been informed by the Ministry of Industry and Information Technology that in order to further implement the major decisions on strengthening the construction of a network power and improving people's quality of life, we will further improve the coverage quality of 5G signals in rural and remote areas, and increase the support and guarantee of radio spectrum resources for 5G high-quality development. The Ministry of Industry and Information Technology approved China Unicom to re-use the frequency resources in the 904-915Acc949-960MHz band (900MHz band) currently used in the 2G/3G/4G system for the 5G system.

6. Kang Fang Bio-B: PD-1/VEGF,AK112 combined with chemotherapy in the treatment of locally advanced or metastatic non-squamous non-small cell lung cancer with EGFR-TKI-resistant EGFR mutation completed the III phase clinical trial.

$AKESO, INC. - B (09926.HK)$Announced that the company independently developed the world's first bispecific antibody drug PD-1/VEGF,AK112 combined with chemotherapy in the treatment of locally advanced EGFR-TKI-resistant EGFR mutations or metastatic non-squamous non-small cell lung cancer (nsq-NSCLC) III phase clinical trials have been completed.

Performance forecast

Sinopharm Technology Co., Ltd. (08156) Yingxi: it is expected to turn a loss into a profit of more than HK $4 million in the first quarter.

REPUBLIC HC (08357) made a net loss of about S $1.2 million in the first three quarters of the year.

ISP GLOBAL (08487) earnings warning: expected net loss in the first quarter is about S $1.1 million-1.3 million

Operation data

The contract sales of Yuexiu Real Estate (00123) in October was about 11.44 billion yuan, up about 9% from the same period last year.

Jindi Merchants (00535) accumulated contract sales of 49.735 billion yuan from January to October.

Dafa Real Estate (06111) realized cumulative contract sales of 5.372 billion yuan in the first 10 months.

Jingrui Holdings (01862) signed a total contract sales of 6.293 billion yuan in the first ten months.

Sino International (00732) had a consolidated net operating volume of about HK $1.41 billion in October, a decrease of about 24.7% compared with the same period last year.

Increase and decrease holdings

Longfor Group (00960) and his controlling shareholders bought $4 million and $5.2 million of preferred notes, respectively.

Sima Ophthalmology (03309) further increased its stake in 950000 shares by Lin Shunchao, chairman of the company.

Five directors and senior managers of Cosco Heineng (01138) plan to reduce their holdings within 6 months after 15 trading days.

Merger and acquisition and sale

Shanghai Industrial Environment (00807) plans to acquire 100% stake in Yunshui Technology for 296 million yuan.

Riel Group (06639) Shenzhen Ruijian agrees to subscribe for 20% registered capital of joint venture company Jinyaori Medical Technology.

Zhuo Hang Holdings (01865) may acquire Zhongshan Jiantai Electric Manufacturing holding interest

Yidu (International Holdings) (00259) sold a further 7.683 million shares of Nantong Jianghai shares, cashing out about 167 million yuan

Zhongda Group Holdings (00139) subsidiaries further sold 63.489 million shares of Sangao Holdings at HK $136 million

Investment and operation

Heyu-B (02256): Heyu Medicine's "pan-FGFR inhibitor ABSK091" and BeiGene, Ltd. 's "tirelizumab" were combined to complete the clinical phase II trial of urothelial cancer. The first patient was enrolled in the group.

Kangfang Bio-B (09926): PD-1/VEGF,AK112 combined with chemotherapy in the treatment of locally advanced or metastatic non-squamous non-small cell lung cancer with EGFR-TKI-resistant EGFR mutation completed the III phase clinical trial.

The application for registration of desloratadine oral solution developed by Shanghai Fosun Pharmaceutical (02196) subsidiary was accepted.

Lizhu Medicine (01513) Alprazole pellets enteric-coated tablets approved in clinical trials

Changfei Optical Fiber and Optical Cable (06869): plans to subscribe for 300548.SZ shares with a subscription price of no more than 387 million yuan

Smoore International Holdings Limited (06969): about 22% of the group's revenue in the third quarter came from Chinese mainland.

Cornerstone Technology Holdings (08391): enter into a partnership with China Energy Conservation and Environmental Protection Group on the provision of electric vehicle charging services to the leading real estate investment trust fund.

Tianjie Environment (01527) the land of Xinle Village, Paitou Town, Zhuji City, Zhejiang Province was expropriated at a total cost of 203 million yuan.

Zhongneng International Holdings (01096) enters into an investment framework agreement with Palace Sea Limited

Beijing Energy International (00686) affiliated with Baoshan SASAC to enter into an agreement on payment of intention payment

The additional issue of Junshi Bio (01877) A shares has been approved by the China Securities Regulatory Commission.

Repurchase cancellation

Xingsheng Commercial (06668) intends to buy back no more than 10% of the company's shares

AIA Group Limited (01299) spent HK $225 million to buy back 3.57 million shares on November 3

China Petroleum & Chemical Corporation (00386) spent HK $65.115 million to buy back 20.234 million shares on November 3

Zijin Mining Group (02899) spent 16.1665 million yuan to buy back 2 million A shares on November 3.

Swire AG A (00019) spent HK $20.6 million to buy back 384500 shares on November 3.

CK Asset (01113) spent HK $21.884 million to buy back 500000 shares on November 3

Haier Smart Home (06690) spent HK $14.4913 million on November 3 to buy back 700000 shares

China Literature (00772) spent HK $4.4261 million to buy back 200000 shares on November 3

Yum China (09987) spent about US $2 million to buy back 42100 shares on November 2nd.

Greentown Service (02869) purchased 1.114 million shares at a cost of HK $3.9937 million on November 3rd

Xiehe New Energy (00182) spent HK $4.9008 million to buy back 7.95 million shares on November 3rd.

Kangji Medical (09997) spent HK $5.18 million to buy back 803500 shares on November 3.

ESR Cayman Limited (01821) spent HK $4.1576 million to buy back 300000 shares on November 3

JD Health (06618) cancelled a total of 6.48515 million repurchased shares on the same day

Tigermed (03347) bought back a total of 3.9098 million A shares by the end of October, involving an investment of about 369 million yuan.

Equity incentive

China Antibody-B (03681) granted 25.156 million share options

Debt financing

Bank of China Ltd. (03988): full redemption of 30 billion yuan of secondary capital bonds